Key result
The prevalence of multiple sclerosis in Isfahan, Iran, reached 73.3 per 100,000 (95% CI 70.9-75.8) by 2010, a sharp increase from 43.8 per 100,000 in 2007.
Observational (n=3,522)
No
There has been a dramatic increase in the prevalence and incidence of multiple sclerosis in Isfahan, Iran, placing it among the regions with the highest prevalence in Asia and Oceania.
Answers are grounded in this paper and cite their sources.
Signals rising MS burden for clinicians in Iran; leaves open incidence versus diagnostic factors and requires longitudinal studies.
BACKGROUND: The epidemiology of multiple sclerosis (MS) has changed in recent decades. OBJECTIVES: This study aimed to give an update on the prevalence and incidence of MS in Isfahan, Iran. METHODS: The study population was all residents of Isfahan province during the period from April 2003 to July 2010. In April 2003, a registry of MS patients was created at the Isfahan MS Society (IMSS), which is the only referral center for MS patients in the province. Nearly all MS patients in Isfahan province are now registered with IMSS and were included in the analysis. RESULTS: Among the 3522 registered patients, 2716 were female and 806 were male (sex ratio: 3.37 : 1), and 431 were diagnosed in 2009. This results in a prevalence figure of 73.3 (95% CI: 70.9-75.8) and an incidence of 9.1 (95% CI: 8.3-10.0) per 100,000. CONCLUSION: The reported prevalence and incidence figures in our study were higher than in our previous report of 2007, in which the prevalence and incidence of MS were reported to be 43.8 and 3.64 per 100,000, respectively. This dramatic increase in the prevalence of MS puts Isfahan amongst the regions with the highest prevalence of MS in Asia and Oceania and is mostly due to changing environmental factors, amongst which vitamin D deficiency seems an important factor in our population.
No takes yet. Share an insight, caveat, or question.
Etemadifar et al. (2011) conducted an observational in Multiple sclerosis (n=3,522). Living in Isfahan, Iran vs. Previous report of 2007 was evaluated on Prevalence of multiple sclerosis per 100,000 (95% CI 70.9-75.8). The prevalence of multiple sclerosis in Isfahan, Iran, reached 73.3 per 100,000 (95% CI 70.9-75.8) by 2010, a sharp increase from 43.8 per 100,000 in 2007.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: